ILCA cross over with APPlE!
Stephen L. Chan
@StephenLChan1
Professor at Department of Clinical Oncology in Hong Kong with research interest in HBP cancer
73 Following 250 Followers 99 Posts
Latest posts 5
There are over 200 registrations (both virtual and on-site). We look forward to seeing you!
Looking forward to the @ILCAnews School on #livercancer #HCC #CCA #biliarytractcancer! Thank you @StephenLChan1 for inviting me! @HUNIMED @HumanitasMilanoView quoted post on X
Yes. It’s an interesting paper. HPD occurs in 15% of PD1 treated HCC but not in TKI or BSC. sciencedirect.com/science/articl… @JHepatology
Hyperprogression is more common in HCC than expected during PD-1View quoted post on X
Read the excellent editorial in @JHepatology by prof @StephenLChan1 @CUHKMedicine
journal-of-hepatology.eu/article/S0168-…
Thanks grace. Hope it will still be helpful to both doctors and patients
Very important review article by @StephenLChan1 and Prof. Masatoshi Kudo - Impacts of #COVID19 on #Liver #Cancers: During and after the Pandemic
karger.com/Article/FullTe…
@CUHKMedicine #HCCView quoted post on X
A new milestone for J hepatology!
We’re happy to announce our new 2019 Journal Impact Factor of 20.582 (up from 18.946). Thanks to our authors, readers, and editorial board for this amazing achievement! @RajivJalan1 @ProfPaoloAngeli @EASLnews
View quoted post on X
